---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-26-001192"
form_type: "8-K/A"
ticker: null
cik: "0001289047"
company_name: "AI Technology Group Inc."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:22:38.847926+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AI Technology Group acquires AVM Biotechnology in share exchange; convertible debentures total $1.587M

## Summary
- Acquired 100% of AVM Biotechnology Inc. (AVMN) on Dec 15, 2025 for 100 common shares of AI Technology Group.
- AVMN outstanding convertible debentures of $1,587,000 convertible into 634,800 common shares of the Corporation.
- Shares issued in acquisition are restricted securities under Rule 144, exempt from registration via Section 4(a)(2).
- Financial statements and pro forma info for AVMN to be filed by amendment within 71 calendar days.

## SEC filing metadata
- accession: 0001477932-26-001192
- form_type: 8-K/A
- cik: 0001289047
- company_name: AI Technology Group Inc.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.01, 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1289047/000147793226001192/0001477932-26-001192-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1289047/000147793226001192/aipg_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-26-001192
- JSON: https://secwatch.observer/filing/0001477932-26-001192.json
- Plain text: https://secwatch.observer/filing/0001477932-26-001192.txt

## Source-grounded claims
- claim_id: e3b4c94d9b5926f418c57a8dd97fbed6b584f4d6
  claim: AI Technology Group Inc. completed an acquisition involving Biomed 360 Solutions Corp. (closed 2025-12-15).
  evidence_excerpt: On December 15, 2025, the Corporation completed the acquisition of AVMN. · Consideration: 100 common shares of the Corporation issued to Biomed 360 in exchange for 100 common shares of AVM. · Result: AVMN is now a wholly-owned subsidiary of the Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289047/000147793226001192/0001477932-26-001192-index.htm
- claim_id: f174005898ecb25c55d08211afab1ba9ed516017
  claim: AI Technology Group Inc. entered into Share Exchange Agreement with AVM Biotechnology Inc. valued at Acquisition of 100% of AVMN shares for 100 common shares of Corporation (effective 2025-12-15).
  evidence_excerpt: On December 15, 2025, AI Technology Group Inc. (the “Corporation”) entered into a Share Exchange Agreement as amended hereto with AVM Biotechnology Inc. , a Nevada corporation (“AVMN”), and Biomed 360 Solutions Corp. , a British Columbia corporation (“Biomed 360”), the sole shareholder of AVMN. Under the terms of the agreement, the Corporation agreed to acquire 100% of the issued and outstanding shares of AVMN in exchange for 100 common shares of the Corporation .
  evidence_url: https://www.sec.gov/Archives/edgar/data/1289047/000147793226001192/0001477932-26-001192-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.